SPI Americas Hosting Regulatorio vs bioaccess® LATAM Registration Holder

SPI Americas vs bioaccess®: what SPI Americas publishes, and when a one-country or dossier partner is enough versus the bioaccess® registration holder across Latin America.

SPI Americas shows up when manufacturers search for a Latin American registration holder or sanitary-registration partner. This article uses only what SPI Americas publishes on its own site (spiamericas.com/asuntos-regulatorios), then compares it with the multi-country subscription from bioaccess®. It is a practitioner comparison, not a teardown.

What SPI Americas publishes

SPI Americas is a Colombia-based firm with intellectual property, corporate law and regulatory practices, active in Colombia and Latin America since 1993. Its regulatory affairs page covers INVIMA and SIC registrations, post-registration modifications, establishment inscriptions, import issues, regulatory due diligence, and translations and legalizations. It also sells a Marketing Authorization Holder (MAH) service: when a foreign company cannot hold the registration, SPI acts as holder in the countries that require it and answers to the authorities. Medical devices appear among its guides and client examples.

SPI Americas vs bioaccess®

Dimension SPI Americas bioaccess®
Public product Marketing Authorization Holder (MAH) where required + INVIMA registrations, modifications and import support LATAM medical device registration: registration, in-country holder, certified translations, government fees up to a stated cap, tecnovigilancia (import shipments quoted separately)
Geography Colombia and Latin America 19 LATAM markets
Public pricing None published Published two-part pricing: a one-time registration fee by country and class, plus an annual holder fee from year 2 (rate card)
Holder vs distributor Acts as registration holder in the countries that require a local holder, and represents the client before the regulatory authorities Holds through its own in-country entities, with defined transfer provisions; the registration is never leverage
Bridge from a clinical trial None published Trial-to-Market continuity: the same partner that ran your FIH study can carry registration (see market access)

Where each one fits

If Colombia is the anchor market and you also want IP or corporate counsel from the same firm, SPI Americas is a sensible pick.

The LATAM medical device registration service from bioaccess® is a different product. bioaccess® registers already FDA-cleared or CE-marked devices and holds them through its own in-country entities across 19 Latin American markets, including COFEPRIS, ANVISA, INVIMA, ANMAT, ISP and DIGEMID. Pricing is published as two parts: a one-time registration fee by country and device class, plus an annual holder fee from year 2 (see the rate card). Initial government fees and certified translations are included up to a stated cap, and the first 12 months of holder service are included (importer-of-record shipments are priced separately on the hub). For multi-country pricing, contact us or see the rate card. The registration is held for the manufacturer’s benefit, with defined transfer provisions if you ever change partners or set up your own entity.

One country and one local partner is enough? Hire the firm that publishes that job. Several LATAM labels under one holder who is not your distributor? Start at bioaccess® market access, read the LATAM importer of record guide, try the LATAM Launch Calculator, or request a registration quote.

Competitor facts from the SPI Americas public pages linked above, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented clients, prices or contacts.

← Back to Blog · Contact bioaccess®